Abbott Laboratories (ABT) Stock: Buy, Sell, or Hold?
$108.31
-0.98 (-0.90%)
âŧ
5d:
-4.66%
30d:
+5.19%
90d:
-2.64%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 21, 2026
0d
Protect ABT Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (41%)
Quality Score
38/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$100.29 â $109.39
Position: SLIGHTLY HIGH
Forward P/E & Valuation
18.4x
FAIR
vs 17.5x historical avg
Wall Street Target
$118.91
+8.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$103.00 / $117.07
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: ABT is fairly priced but lacks strong directional signals. At 1.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 5, 2026 at $113.60 · last confirmed Nov 9, 2026
Strength: 6.2/10
Get Alerted When ABT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$137.68
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$85.49
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ABT is currently trading at $108.31, which is considered slightly high relative to its 30-day fair value range of $100.29 to $109.39. The stock's valuation (Forward PE: 18.4) is in line with its historical norms (17.5). At these levels, the market is pricing in 1.8% annual earnings growth.
Technical Outlook: Technically, ABT is in a downtrend. Immediate support is located at $103.00, while resistance sits at $117.07.
Market Sentiment: ABT scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABT is in a downtrend. Immediate support is located at $103.00, while resistance sits at $117.07.
Market Sentiment: ABT scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$100.29 -
$109.39
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
41.4%
Trading Range & Key Levels
30-Day Trading Range
$100.29 -
$109.39
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$103.00
Resistance Level
$117.07
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding ABT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($118.91)
- BULLISH: Expecting earnings turnaround to 1.8% growth with 14.5% revenue growth
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
18.41
Wall Street Target
$118.91
(+8.8%)
Revenue Growth (YoY)
14.5%
Earnings Growth (YoY)
-43.6%
Profit Margin
9.8%
Valuation Premium vs History
+1.8% premium
PE vs Historical
18.4 vs 17.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.8%
(market-implied from PE analysis)
1-Year Target
$111.26
(+2%)
2-Year Target
$113.26
(+4%)
3-Year Target
$115.30
(+6%)
3-Yr Target (if PE normalizes)
(PE: 18â18)
PE COMPRESSION
$109.61
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 7.6%)
$146.81
(+34%)
Base:
(SPY PE: 18.4, Growth: 7.6%)
$136.08
(+25%)
Bear:
(PE: 15.6, Growth: 7.6%)
$115.67
(+6%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 41.22 | Current EPS (TTM): $2.68
Bull Case
$243.01
(+122%)
Analyst growth 100.0%, PE expands to 45.3
Base Case
$220.92
(+102%)
Market implied 100.0%, PE stable at 41.2
Bear Case
$75.11
(-31%)
Severe decline -20.0%, PE contracts to 35.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share ABT Analysis
Share this live ABT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ABT)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user expresses satisfaction with pending dividend reinvestment and optimistic outlook on $ABT
Key Retail Themes:
bullish sentiment towards $ABT
anticipation for dividend reinvestment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 10:30 AM ET
Data refreshes hourly during market hours. Next update: 11:30 AM
Data refreshes hourly during market hours. Next update: 11:30 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 45 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Advanced ABT Option Strategies
Professional options setups generated by AI based on today's ABT price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ABT Research Pages
